Back to mobile site

INmune Bio, Inc. (INMB) Tops Q2 EPS by 14c

August 6, 2026 5:38 PM EDT

INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.05), $0.14 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK